Kliničke studije za Lupus u državi Louisiana
9 studija za Lupus traži sudionike na lokacijama u državi Louisiana.
Gradovi u državi Louisiana
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50023, Baton Rouge
- Sl0044 50285, Lake Charles
- Sl0044 50660, New Orleans
U tijeku regrutacijaFaza 3
Od 16 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ochsner Health System, New Orleans
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05268289Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Accurate Clinical Research, Lake Charles
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, New Orleans
U tijeku regrutacijaFaza 3
Od 5 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05835310A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Lake Charles
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Accurate Clinical Research, Inc., Lake Charles
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07438496A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Accurate Clinical Research Inc. - Lake Charles, Lake Charles
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07355218A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Tulane University Medical Center, New Orleans
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 28. kol 2026. · NCT06925542A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- University Medical Center New Orleans, New Orleans
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 21. kol 2026. · NCT06570798Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.